We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $10.9B
1-Year Est. Return 70.31%
This Fund
S&P 500
This Quarter Est. Return
+4.71%
1 Year Est. Return
+70.31%
3 Year Est. Return
+250.68%
5 Year Est. Return
+304.91%
10 Year Est. Return
–
AUM
$9.44B
AUM Growth
+$1.08B
Cap. Flow
-$287M
Cap. Flow %
-3.05%
Top 10 Hldgs %
56.7%
Holding
92
New
16
Increased
26
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$112M
2
ZM icon
Zoom
ZM
+$83.8M
3
GIL icon
Gildan
GIL
+$73.7M
4
EPC icon
Edgewell Personal Care
EPC
+$60.3M
5
AMCR icon
Amcor
AMCR
+$56.1M

Top Sells

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$298M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$196M
3
FLR icon
Fluor
FLR
+$164M
4
ROIV icon
Roivant Sciences
ROIV
+$103M
5
VST icon
Vistra
VST
+$80.9M

Sector Composition

Rank Sector Weight
1 Healthcare 27.66%
2 Utilities 19.69%
3 Miscellaneous 13.55%
4 Industrials 9.76%
5 Energy 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZM icon
26
Zoom
ZM
$29.4B
$80.5M 0.85%
+1,001,006
New +$83.8M
TDS icon
27
Telephone and Data Systems
TDS
$3.82B
$77.9M 0.83%
1,850,000
– –
GIL icon
28
Gildan
GIL
$9.86B
$77.7M 0.82%
1,395,790
+1,139,392
+444% +$73.7M
IART icon
29
Integra LifeSciences
IART
$1.31B
$73M 0.77%
7,753,934
– –
SDGR icon
30
Schrodinger
SDGR
$1.53B
$68.2M 0.72%
6,000,000
+1,828,502
+44% +$25.3M
SPRY icon
31
ARS Pharmaceuticals
SPRY
$600M
$64.2M 0.68%
8,000,000
+1,800,000
+29% +$17.3M
GEO icon
32
The GEO Group
GEO
$4.29B
$62.9M 0.67%
3,743,180
+256,265
+7% +$4.07M
SSYS icon
33
Stratasys
SSYS
$699M
$62.5M 0.66%
8,000,000
+659,974
+9% +$6.46M
ANDE icon
34
Andersons Inc
ANDE
$2.17B
$61.4M 0.65%
855,819
-149,812
-15% -$9.62M
MGTX icon
35
MeiraGTx Holdings
MGTX
$1.36B
$60.6M 0.64%
7,000,000
+824,669
+13% +$6.26M
ENOV icon
36
Enovis
ENOV
$1.43B
$55.8M 0.59%
2,453,265
– –
OPK icon
37
Opko Health
OPK
$1.12B
$54.5M 0.58%
47,791,243
– –
QDEL icon
38
QuidelOrtho
QDEL
$1.05B
$54.3M 0.58%
3,306,281
-470,876
-12% -$11.6M
PRMB
39
Primo Brands
PRMB
$8.12B
$52.4M 0.56%
2,782,404
-846,411
-23% -$16.4M
NWL icon
40
Newell Brands
NWL
$2.5B
$52.3M 0.55%
15,257,431
+2,257,431
+17% +$9.48M
AMCR icon
41
Amcor
AMCR
$21.5B
$50.5M 0.53%
+1,269,396
New +$56.1M
RNW icon
42
ReNew
RNW
$2.49B
$50.4M 0.53%
11,000,000
– –
PRTA icon
43
Prothena Corp
PRTA
$467M
$48.6M 0.51%
5,000,000
+1,322,669
+36% +$12.1M
PTGX icon
44
Protagonist Therapeutics
PTGX
$9.67B
$45.1M 0.48%
+427,998
New +$37.9M
TRVI icon
45
Trevi Therapeutics
TRVI
$2.56B
$44.3M 0.47%
3,712,373
-54,376
-1% -$609K
OFIX icon
46
Orthofix Medical
OFIX
$392M
$42.7M 0.45%
3,721,715
– –
COLL icon
47
Collegium Pharmaceutical
COLL
$820M
$42.3M 0.45%
1,279,611
-216,825
-14% -$9.18M
CXW icon
48
CoreCivic
CXW
$3.34B
$38.9M 0.41%
2,059,216
+97,770
+5% +$1.84M
NRIX icon
49
Nurix Therapeutics
NRIX
$2.79B
$38.3M 0.41%
2,473,885
– –
DRVN icon
50
Driven Brands
DRVN
$2.09B
$37.8M 0.4%
+3,000,000
New +$42.2M
1
2
3 4

Similar funds

MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.9B AUM 37.22% 1-Year Est. Return
LCAM
London & Capital Asset Management London, United Kingdom $10.9B AUM 39.88% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
RCMF
RK Capital Management (Florida) Weston, Florida $10.8B AUM 53.02% 1-Year Est. Return
SIM
SRS Investment Management New York $10.8B AUM 34.05% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Rubric Capital Management (New York)'s Q1 2026 Portfolio in Review

As of Q1 2026, Rubric Capital Management (New York) held 92 positions worth $9.44B, up 13% from $8.36B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Rubric Capital Management (New York) withdrew a net $287M in Q1 2026, closing 9 positions and reducing 14 holdings. Its most notable exit was Fluor, an estimated $164M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 33% a quarter earlier, followed by Utilities and Miscellaneous.

Against the trend, Rubric Capital Management (New York) opened a new position in Zoom worth $80.5M.

  • Rubric Capital Management (New York)'s largest Q1 2026 buy was Zoom: 1,001,006 shares worth $80.5M.
  • Rubric Capital Management (New York) added most to Viatris in Q1 2026, an estimated $112M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $298M.
  • Rubric Capital Management (New York) fully exited Fluor in Q1 2026, selling an estimated $164M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 57% of its $9.44B portfolio in Q1 2026.
  • Rubric Capital Management (New York) opened 16 new positions and closed 9 in Q1 2026.
  • Rubric Capital Management (New York)'s portfolio value rose 13% quarter-over-quarter to $9.44B.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2026, filed 15 May 2026.